In previous reports, EZH2 was already shown to contribute to melanoma progression by silencing distinct tumor suppressor genes [33,50], which results in aggressive tumor subgroups of cutaneous melanoma with higher proliferation rates and increased metastasis [33,38,44,51]. This evidence concerns the gene EZH2 and neoplasm.